Analysis of current approaches to the treatment and quality of life improvement in patients with gastroesophageal reflux disease in case of its combination with the syndrome of undifferentiated connective tissue dysplasia


  • Iryna Romash Ivano-Frankivsk National Medical University



quality of life, gastroesophageal reflux disease, undifferentiated connective tissue dysplasia


When the structure of the connective tissue is disturbed, the probability of developing pathology of the internal organs increases. The gastrointestinal tract is one of the systems that is most often involved in the pathological process in the case of such disorders. Due to its mesenchymal origin, the esophagus is one of the first to suffer.

Normalization of mineral metabolism, correction of immunological and bioenergetic status are the main tasks in the treatment of such patients. Therapy with magnesium drugs, vitamins, anabolic drugs, ?-blockers, aldosterone antagonists, and amino acid drugs should also be used for this purpose. Patients in this group should also take drugs that contain vitamin D3


Akyüz, F., Mutluay Soyer, Ö. (2017). Which diseases are risk factors for developing gastroesophageal reflux disease? Turk J Gastroenterol. (1):44-47. DOI:

Antunes, M., Scirè, C.A., Talarico, R. et al. (2019). Undifferentiated connective tissue disease: state of the art on clinical practice guidelines. RMD Open.;4:e000786. DOI:

Bodolay, E., Csiki, Z., Szekanecz, Z., Ben, T., Kiss, E., Zeher, M., Szücs, G., Dankó, K., Szegedi, G. (2003). Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol. 21(3):313-20.

Butkova, O.I., Zhabchenko, I.A., Oleshko, V.A. (2018). Features of the microelements exchange and connective tissue state in the first-pregnant women with a disruption of cervical ripening in the second half of pregnancy. Medical aspects of women's health. 3(116):11-15.

Chernobrovyj, V.M., Melashchenko, S.G., Chernobrova, O.I., Ksenchyn, O. O. (2017). Gastroesophageal reflux disease: the main accents of modern differentiated and controlled pharmacotherapy. Modern gastroenterology. 4(96):33-42.

Coyle, C., Crawford, G., Wilkinson, J., Thomas, S.J., Bytzer, P. (2017). Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms. Aliment Pharmacol Ther.45(12):1524-33. DOI:

García-González, M., Rodríguez-Lozano, B., Bustabad, S., Ferraz-Amaro, I. (2017). Undifferentiated connective tissue disease: predictors of evolution into definite disease. Clin Exp Rheumatol. 35(5):739-45. [176].

Iudici, M., Irace, R., Riccardi, A., Cuomo, G., Vettori, S., Valentini, G. (2017). Longitudinal analysis of quality of life in patients with undifferentiated connective tissue diseases. Patient Relat Outcome Meas. 8:7-13. DOI:

Januszewicz, W., Hartley, J., Waldock, W., Roberts, G., Alias, B., Hobson, A., Wernisch, L., di Pietro, M. (2019). Endoscopic measurement of gastric pH associates with persistent acid reflux in patients treated with proton-pump inhibitors for gastroesophageal reflux disease. United European Gastroenterol J. Dec 1;7(10):1389-98. DOI:

Leiman, D.A., Kochar, B., Posner, S., Fan, C., Patel, A., Shaheen, O.A. et al. (2018). A diagnosis of eosinophilic esophagitis is associated with increased life insurance premiums. Diseases of the Esophagus. 31:1-5. DOI:

Mishchuk, V. G., Romash, I. B. (2019). The specific features of syndrome of undifferentiated connective tissue dysplasia and collagen exchange indices in case of its combination with the gastroesophageal reflux disease. 3(107):68-74. DOI:

Mosca, M., Tani, C., Vagnani, S., Carli, L., Bombardieri, S. (2014). The diagnosis and classification of undifferentiated connective tissue diseases. J. Autoimmun. 48-49:50 -2. DOI:

Müller, M., Labenz, G., Borkenstein, D-P., Labenz J. (2019). Alginat bei Bedarf als Add-on bei unzureichendem Effekt von Protonenpumpen-Hemmern bei Patienten mit gastroösophagealer Reflux-Krankheit. DMW - Deutsche Medizinische Wochenschrift 144:e30–5. DOI:

Omelchenko, L.I., Mukvich, O.M., Lavrenchuk, O.V. (2017). On vitamin D-dependent regulation of local mechanisms of non-specific defense in children with connective tissue dysplasia. CHILD`S HEALTH, 12(8), 890–894. DOI:

Romash, IB. (2019). Peculiarities of the course and treatment of gastroesophageal reflux disease in patients with syndrome of undifferentiated connective tissue dysplasia. (Systematic literature review). MHGCJ [Internet]. Dec. 27 [cited 2021 Feb. 22];:76-8. DOI:

Romash, I. B., Mishchuk, V. G., Ersteniuk G.M. (2019). Level of different micro and macroelements and activity of matrix metalloproteinase 9 in patients with gastroesophageal reflux disease that developed against the background of undifferentiated connective tissue dysplasia 4:5-11. DOI:

Sawada, A., Sifrim, D. (2020). Reply. Clinical Gastroenterology and Hepatology. 1

Sharma, P., Yadlapati, R. (2020). Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid. Ann N Y Acad Sci. DOI:

Solieiko, O.V., Rykalo, N.A., Osypenko, I.P., Soleiko, L.P. (2014). Syndrome of undifferentiated connective tissue dysplasia: from the concept of pathogenesis to treatment strategy. Study guide for students. higher honey. textbook institutions of III-IV levels of accreditation. Vinnytsia: Nova knyha;. 168 s.

Surdea-Blaga, T., B?ncil?, I., Dobru, D., Drug, V., Fr??il?, O., Goldi?, A. (2016). Mucosal Protective Compounds in the Treatment of Gastroesophageal Reflux Disease. A Position Paper Based on Evidence of the Romanian Society of Neurogastroenterology. J Gastrointestin Liver Dis. 25 (4):537-46 DOI:




How to Cite

Romash, I. (2021). Analysis of current approaches to the treatment and quality of life improvement in patients with gastroesophageal reflux disease in case of its combination with the syndrome of undifferentiated connective tissue dysplasia. Mental Health: Global Challenges Journal, 4(2).